RNA interference as a new strategy against viral hepatitis

Virology

Volumn 323, Issue 2, 2004, Pages 173-181

  Radhakrishnan, Senthil K ^a   Layden, Thomas J ^a   Gartel, Andrei L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

dsRNA; RNA interference; Viral hepatitis

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; DOUBLE STRANDED RNA; FAMCICLOVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PENCICLOVIR; PROTEINASE INHIBITOR; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; SMALL INTERFERING RNA;

CLINICAL TRIAL; DNA VECTOR; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA DEGRADATION; RNA INTERFERENCE; RNA SEQUENCE; SEQUENCE HOMOLOGY; SHORT SURVEY; VIRUS GENOME; VIRUS HEPATITIS; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 2942527527     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.02.021     Document Type: Review

References (75)

1. Adelman Z.N., Blair C.D., Carlson J.O., Beaty B.J., Olson K.E. Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol. Biol. 10(3):2001;265-273
2. Adelman Z.N., Sanchez-Vargas I., Travanty E.A., Carlson J.O., Beaty B.J., Blair C.D., Olson K.E. RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome. J. Virol. 76(24):2002;12925-12933
3. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity. 13(1):2000;129-141
4. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409(6818):2001;363-366
5. Bitko V., Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1(1):2001;34
6. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science. 290(5498):2000;1972-1974
7. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34(3):2003;263-264
8. Brigneti G., Voinnet O., Li W.X., Ji L.H., Ding S.W., Baulcombe D.C. Viral pathogenicity determinants are suppressors of transgene silencing in nicotiana benthamiana. EMBO J. 17(22):1998;6739-6746
9. Cagnon L., Rossi J.J. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts. Antisense Nucleic Acid Drug Dev. 10(4):2000;251-261
10. Caplen N.J., Zheng Z., Falgout B., Morgan R.A. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Molec. Ther. 6(2):2002;243-251
11. Capodici J., Kariko K., Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169(9):2002;5196-5201
12. Chang J., Taylor J.M. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J. Virol. 77(17):2003;9728-9731
13. Chang J., Provost P., Taylor J.M. Resistance of human hepatitis delta virus RNAs to dicer activity. J. Virol. 77(22):2003;11910-11917
14. Coburn G.A., Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76(18):2002;9225-9231
15. Cordelier P., Morse B., Strayer D. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-Tropic HIV. Oligonucleotides. 13(5):2003;281-294
16. Dector M.A., Romero P., Lopez S., Arias C.F. Rotavirus gene silencing by small interfering RNAs. EMBO Rep. 3(12):2002;1175-1180
17. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411(6836):2001;494-498
18. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391(6669):1998;806-811
19. Ganem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:1987;651-693
20. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U.S.A. 100(5):2003;2718-2723
21. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O., Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Molec. Ther. 8(5):2003;769-776
22. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418(6896):2002;430-434
23. Gudima S., Chang J., Moraleda G., Azvolinsky A., Taylor J. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J. Virol. 76(8):2002;3709-3719
24. Guo J.T., Zhu Q., Seeger C. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. J. Virol. 77(20):2003;10769-10779
25. Haasnoot P.C., Bol J.F., Olsthoorn R.C. A plant virus replication system to assay the formation of RNA pseudotriloop motifs in RNA-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 100(22):2003;12596-12600
26. Hadler S.C., Alcala de Monzon M., Rivero D., Perez M., Bracho A., Fields H. Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am. J. Epidemiol. 136(12):1992;1507-1516
27. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H., Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543(1-3):2003;51-54
28. Hannon G.J. RNA interference. Nature. 418(6894):2002;244-251
29. Hollinger FB L.T. Hepatitis B Virus. Knipe D.M., et al. Fields Virology. 4th ed. 2001;2971-3036 Lippincott Williams and Wilkins, Philadelphia
30. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12(15):2002;1301-1311
31. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21(6):2003;635-637
32. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature. 418(6896):2002;435-438
33. Kapadia S.B., Brideau-Andersen A., Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100(4):2003;2014-2018
34. Kasschau K.D., Carrington J.C. A counterdefensive strategy of plant viruses: suppression of posttranscriptional gene silencing. Cell. 95(4):1998;461-470
35. Keskinen P., Nyqvist M., Sareneva T., Pirhonen J., Melen K., Julkunen I. Impaired antiviral response in human hepatoma cells. Virology. 263(2):1999;364-375
36. Klein C., Bock C.T., Wedemeyer H., Wustefeld T., Locarnini S., Dienes H.P., Kubicka S., Manns M.P., Trautwein C. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology. 125(1):2003;9-18
37. Konishi M., Wu C.H., Wu G.Y. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology. 38(4):2003;842-850
38. Lamarre D., Anderson P.C., Bailey M., Beaulieu P., Bolger G., Bonneau P., Bos M., Cameron D.R., Cartier M., Cordingley M.G., Faucher A.M., Goudreau N., Kawai S.H., Kukolj G., Lagace L., LaPlante S.R., Narjes H., Poupart M.A., Rancourt J., Sentjens R.E., St George R., Simoneau B., Steinmann G., Thibeault D., Tsantrizos Y.S., Weldon S.M., Yong C.L., Llinas-Brunet M. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature. 426(6963):2003;186-189
39. Lanford R.E., Guerra B., Lee H., Averett D.R., Pfeiffer B., Chavez D., Notvall L., Bigger C. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J. Virol. 77(2):2003;1092-1104
40. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20(5):2002;500-505
41. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 337(24):1997;1733-1745
42. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32(1):2002;107-108
43. Li H., Li W.X., Ding S.W. Induction and suppression of RNA silencing by an animal virus. Science. 296(5571):2002;1319-1321
44. Li W.-X., Li H., Lu R., Li F., Dus M., Atkinson P., Brydon E.W.A., Johnson K.L., Garcia-Sastre A., Ball L.A., Palese P., Ding S.-W. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. 101(5):2004;1350-1355
45. Liaw Y.F. Management of patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 17(4):2002;406-408
46. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 285(5424):1999;110-113
47. Macnaughton T.B., Lai M.M. Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J. Virol. 76(8):2002;3928-3935
48. Martinez M.A., Gutierrez A., Armand-Ugon M., Blanco J., Parera M., Gomez J., Clotet B., Este J.A. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. Aids. 16(18):2002;2385-2390
49. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., Kay M.A. RNA interference in adult mice. Nature. 418(6893):2002;38-39
50. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21(6):2003;639-644
51. McManus M.T., Petersen C.P., Haines B.B., Chen J., Sharp P.A. Gene silencing using micro-RNA designed hairpins. RNA. 8(6):2002;842-850
52. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8(7):2002;681-686
53. Paddison P.J., Hannon G.J. RNA interference: the new somatic cell genetics? Cancer Cells. 2(1):2002;17-23
54. Park W.S., Miyano-Kurosaki N., Hayafune M., Nakajima E., Matsuzaki T., Shimada F., Takaku H. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res. 30(22):2002;4830-4835
55. Qin X.F., An D.S., Chen I.S., Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 100(1):2003;183-188
56. Randall G., Grakoui A., Rice C.M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100(1):2003;235-240
57. Scacheri P.C., Rozenblatt-Rosen O., Caplen N.J., Wolfsberg T.G., Umayam L., Lee J.C., Hughes C.M., Shanmugam K.S., Bhattacharjee A., Meyerson M., Collins F.S. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2004
58. Scherer L.J., Rossi J.J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21(12):2003;1457-1465
59. Seo M.Y., Abrignani S., Houghton M., Han J.H. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol. 77(1):2003;810-812
60. Shi Y. Mammalian RNAi for the masses. Trends Genet. 19(1):2003;9-12
61. Shlomai A., Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology. 37(4):2003;764-770
62. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5(9):2003;834-899
63. Soler M., Pellerin M., Malnou C.E., Dhumeaux D., Kean K.M., Pawlotsky J.M. Quasispecies heterogeneity and constraints on the evolution of the 5′ noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. Virology. 298(1):2002;160-173
64. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9(3):2003;347-351
65. Surabhi R.M., Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76(24):2002;12963-12973
66. Vaucheret H., Beclin C., Fagard M. Post-transcriptional gene silencing in plants. J. Cell Sci. 114(Pt 17):2001;3083-3091
67. Voinnet O., Pinto Y.M., Baulcombe D.C. Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc. Natl. Acad. Sci. U.S.A. 96(24):1999;14147-14152
68. Wilson J.A., Jayasena S., Khvorova A., Sabatinos S., Rodrigue-Gervais I.G., Arya S., Sarangi F., Harris-Brandts M., Beaulieu S., Richardson C.D. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. U.S.A. 100(5):2003;2783-2788
69. Yamamoto T., Omoto S., Mizuguchi M., Mizukami H., Okuyama H., Okada N., Saksena N.K., Brisibe E.A., Otake K., Fuji Y.R. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol. Immunol. 46(11):2002;809-817
70. Ye K., Malinina L., Patel D.J. Recognition of small interfering RNA by a viral suppressor of RNA silencing. Nature. 426(6968):2003;874-878
71. Ying C., De Clercq E., Neyts J. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem. Biophys. Res. Commun. 309(2):2003;482-484
72. Yokota T., Sakamoto N., Enomoto N., Tanabe Y., Miyagishi M., Maekawa S., Yi L., Kurosaki M., Taira K., Watanabe M., Mizusawa H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4(6):2003;602-608
73. Zamore P.D. RNA interference: listening to the sound of silence. Nat. Struct. Biol. 8(9):2001;746-750
74. Zeng Y., Cullen B.R. RNA interference in human cells is restricted to the cytoplasm. RNA. 8(7):2002;855-860
75. Zhang G., Budker V., Williams P., Subbotin V., Wolff J.A. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12(4):2001;427-438